Home/Filings/4/0001600132-17-000071
4//SEC Filing

Bellerophon Therapeutics, Inc. 4

Accession 0001600132-17-000071

CIK 0001600132operating

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 6:50 AM ET

Size

4.5 KB

Accession

0001600132-17-000071

Insider Transaction Report

Form 4
Period: 2017-06-28
Amin Naseem
Director
Transactions
  • Award

    Common Stock

    2017-06-28+36,232773,882 total

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001600132

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:50 AM ET
Size
4.5 KB